Our experts attending
Dedicated professionals committed to clinical excellence.
BIO 2026 brings together the global biotechnology community to reconnect around a shared purpose: advancing innovation that improves lives. This year’s event is a reminder of why the industry exists — to solve complex scientific challenges, accelerate new therapies, and deliver better outcomes for patients worldwide.
Meet Southern Star Research at BIO 2026
Southern Star Research is proud to attend BIO International Convention 2026 alongside the world’s leading biotechnology and pharmaceutical innovators.
If your organization is preparing for first-in-human, first-in-patient or Phase II clinical development, we invite you to meet with our team to explore how we can help accelerate your program through Australia and the broader APAC region.
At Southern Star Research, we specialise in guiding early-phase clinical trials with precision and foresight. We understand that emerging biotech companies are often balancing ambitious scientific goals with lean internal teams, investor expectations, and compressed development timelines. That’s why we work as a proactive partner — bringing the operational infrastructure, therapeutic expertise, and responsiveness needed to move programs forward with confidence.
As one of the most complete mid-sized CROs in APAC, we combine regional execution capability with the flexibility and personal engagement sponsors often struggle to find in larger CRO models.
Therapeutic Expertise Across Early-Phase Development
Our team has extensive experience supporting complex early-phase studies across a broad range of therapeutic areas, including:
- Oncology
- Central Nervous System (CNS)
- Metabolic and Endocrine Disorders
- Sexual Health
- Vaccines and Infectious Diseases
- Healthy Volunteer Studies
We support sponsors through the unique operational and scientific challenges associated with these programs — from protocol design and feasibility through to site activation, patient recruitment, biomarker strategy, and data delivery.
Our longstanding site relationships across Australia and APAC, combined with strong regulatory expertise, enable efficient study execution while maintaining high-quality, regulator-ready data.
Why Sponsors Choose Southern Star Research
Proactive Partnership
We engage deeply with our clients’ scientific and operational challenges. Our teams apply critical thinking, foresight, and practical expertise to identify risks early and support smarter decision-making throughout the study lifecycle.
Embedded Quality
We define quality not simply as compliance, but as the consistent application of rigor, accountability, and thoughtful execution across every stage of clinical development.
Tailored Execution
Every study is different. Our flexible and hands-on approach allows us to tailor delivery models to your endpoints, timelines, resourcing requirements, and long-term development strategy.
Australia and APAC Advantage
We help sponsors leverage the strategic advantages of Australia and APAC, including:
- Rapid study start-up timelines
- High-quality data accepted by major global regulators
- Access to experienced investigators and diverse patient populations
- Cost efficiencies through Australia’s R&D incentive environment
- Seamless regional expansion across APAC
Connect With Our Team
BIO 2026 is an opportunity to have meaningful conversations about the future of your program and the operational pathways that can help accelerate development.
Whether you are preparing for your first clinical study or planning broader APAC expansion, we look forward to discussing how Southern Star Research can support your next phase of growth.
Schedule a meeting with our team at BIO International Convention 2026 to learn how we can provide efficient, flexible, and strategically aligned CRO support for your upcoming trials.